December 2007 Research News
Avastin survival data mixed in breast cancer
December 26, 2007
Avastin combined with Taxol lengthens the time until advanced breast cancer progresses, but doesn't improve overall survival. Read more...
Hispanic women at risk of breast cancer gene: study
December 26, 2007
A new analysis shows that Hispanic women and young African American women are more likely than white women to have abnormal BRCA1 genes. Read more...
Study fails to tie fat intake to breast cancer risk
December 21, 2007
While there is no clear link between the amount of fat a woman eats and her risk of breast cancer, a new study shows that a diet high in unsaturated fat seems to reduce the risk of breast cancer in women older than 50. Read more...
Chemo, tamoxifen cut risk of second breast cancer
December 25, 2007
Tamoxifen and chemotherapy reduce the risk of developing a new, second breast cancer in the other breast. Read more...
Jury still out on acupuncture for hot flashes
December 21, 2007
A new study still offers mixed results on whether acupuncture can help ease hot flashes. Read more...
Breast reconstruction often not discussed
December 21, 2007
Most surgeons don't talk about reconstruction with women diagnosed with breast cancer. But when reconstruction is discussed, it makes a big difference in which type of surgery is chosen. Read more...
Cancer risk varies in patients with schizophrenia
December 20, 2007
New researcher shows that people diagnosed with schizophrenia have a 50% higher risk of breast cancer. Read more...
Depression might influence breast cancer risk
December 19, 2007
Researchers look for link between depression and breast cancer risk. Read more...
Breast cancer therapy response detected early
December 18, 2007
Measuring circulating tumor cells in the bloodstream may offer doctors a way to tell is chemotherapy is working against metastatic breast cancer. Read more...
Combo therapy with Tykerb fights brain metastases
December 17, 2007
A small study shows that Tykerb (chemical name: lapatinib) combined with Xeloda (chemical name: capecitabine) can stop the growth of HER2-positive breast cancer that has spread to the brain. Read more...
Arimidex most effective in breast cancer study
December 17, 2007
Another year of results from the ATAC trial continues to show that Arimidex has more benefits than tamoxifen for post-menopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer. Read more...
Avoiding weight gain important after breast cancer
December 11, 2007
Women who gain weight after being diagnosed with breast cancer have a worse prognosis than women who don't gain weight. Read more...
Breast cancer survival longer with Taxotere: study
December 13, 2007
The combination of Taxotere (chemical name: docetaxel) and Cytoxan (chemical name: cyclophosphamide) offers better survival and fewer and less severe side effects than the combination of Adriamycin (chemical name: doxorubicin) and Cytoxan for treating breast cancer. Read more...
Genetic test guides cancer treatment, company says
December 13, 2007
The Oncotype DX test can help determine who will benefit from hormonal therapy plus chemotherapy, as opposed to hormonal therapy alone, in post-menopausal women diagnosed with estrogen-receptor-positive, node-positive breast cancer. Read more...
Keeping insulin in check important in breast cancer
December 12, 2007
A new study suggests that lower insulin levels can help improve breast cancer survival. Read more...
Mammogram accuracy varies by radiologist: study
December 11, 2007
The ability of radiologists to accurately read diagnostic mammograms varies widely and radiologists who work at academic medical centers are likely to be more accurate than non-medical center radiologists. Read more...
Extended therapy may benefit breast cancer patients
December 11, 2007
Taking Arimidex for 3 years after 5 years of tamoxifen reduced the risk of the cancer coming back in women diagnosed with hormone-receptor-positive breast cancer. Read more...
Scientists discover how BRCA1 gene causes cancer
December 11, 2007
Researchers seem to have figured out how abnormal BRCA1 genes lead to breast cancer. Read more...
Widely used chemical may raise breast cancer risk
December 6, 2007
A common chemical used in many household products may raise breast cancer risk in rats, which may have implications for people. Read more...
US panel rejects Avastin for use in breast cancer
December 6, 2007
An FDA expert panel recommended that Avastin not be used to treat advanced breast cancer. But doctors may still recommend the medicine depending on a woman's unique situation. Read more...